Home LiteratureArticle Details
PMID: 11342626 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

p27kip protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 166 ·No. 10 ·2001-05-15 ·Pages 6084-90

Velasco-Sampayo A, Alemany S

Abstract

Cot/Tpl-2 kinase, homologous to members of mitogen-activated protein kinase kinase kinase, was initially discovered by its capacity to promote cell transformation. Cot/Tpl-2 mRNA levels are increased during G(0) to G(1) phase progression in T lymphocytes, suggesting a role for this kinase later on in the cell cycle. The IL-2-dependent CTLL-2 cells were used to investigate the role of Cot kinase in G(1) to S phase transition. Transient expression of Cot kinase in CTLL-2 cells increases DNA synthesis triggered by IL-2 and the transient expression of a dominant negative form of Cot kinase in CTLL-2 markedly reduces the DNA synthesis triggered by this cytokine. Cell cycle analysis of synchronized CTLL-2 stabling overexpressing Cot kinase indicates that this kinase contributes to the passage to S and G(2)-M phases of the cell cycle. Cot kinase reduces the levels of the cyclin kinase inhibitor p27(kip), whereas bcl-x(L) expression is unaffected. Cot kinase also increases E2F transcriptional activity in a phosphatidylinositol 3 kinase-independent way and acts in synergy with this kinase. These data give evidence, for the first time, of the regulation of different G(1) progression events by Cot kinase.

MeSH Terms
Cell Cycle Proteins/antagonists & inhibitors,biosynthesis,genetics,metabolism Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors DNA Replication/genetics,immunology DNA-Binding Proteins Down-Regulation/genetics,immunology E2F Transcription Factors G1 Phase/genetics,immunology Gene Expression Regulation/immunology Genetic Vectors/chemical synthesis,immunology Humans Interleukin-2/physiology MAP Kinase Kinase Kinases/antagonists & inhibitors,biosynthesis,genetics,physiology Proto-Oncogene Proteins/antagonists & inhibitors,biosynthesis,genetics,physiology T-Lymphocytes/cytology,enzymology,metabolism Transcription Factors/biosynthesis,genetics,metabolism Transcriptional Activation/immunology Transfection Tumor Cells, Cultured Tumor Suppressor Proteins
Chemicals
Cell Cycle Proteins DNA-Binding Proteins E2F Transcription Factors Interleukin-2 Proto-Oncogene Proteins Transcription Factors Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases MAP Kinase Kinase Kinases MAP3K8 protein, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Velasco-Sampayo A
Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Cientificas, Facultad. Medicina Universidad Autónoma de Madrid, Madrid, Spain.
Alemany S
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2001-05-15
Pages
6084-90
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com